Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide

被引:69
|
作者
Ciardiello, F
Caputo, R
Bianco, R
Damiano, V
Pomatico, G
Pepe, S
Bianco, AR
Agrawal, S
Mendelsohn, J
Tortora, G
机构
[1] Univ Naples Federico II, Fac Med & Chirurg, Cattedra Oncol Med, Dipartimento Endocrinol & Oncol Mol & Clin, I-80131 Naples, Italy
[2] Hybridon Inc, Cambridge, MA USA
[3] Univ Texas, Md Anderson Canc Ctr, Houston, TX USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1998年 / 90卷 / 14期
关键词
D O I
10.1093/jnci/90.14.1087
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The expression of epidermal growth factor receptor (EGFR) and type I cyclic adenosine monophosphate (cAMP)-dependent protein kinase (PKAI) is associated with neoplastic transformation. By use of human renal cancer cell lines (i,e,, 769-P, ACHN, A498, and SW839), we investigated the antiproliferative activity and the antitumor activity of an anti-EGFR humanized chimeric mouse monoclonal antibody, MAb C225, and a novel mixed backbone 18-mer antisense oligonucleotide, HYB 190, that targets expression of the RI alpha regulatory subunit of PKAI, Methods: The antiproliferative activity of MAb C225 and oligonucleotide HYB 190, alone or in combination, on different renal cancer cell lines was determined by monitoring cell growth in soft agar, In addition, the induction of apoptosis by treatment with the anti-EGFR antibody and/or antisense PKAI oligonucleotides was evaluated by flow cytometric analysis of fragmented DNA, The antitumor activity of MAb C225 and oligonucleotide HYB 190 was determined in athymic mice bearing established ACHN tumor xenografts, Cell proliferation and tumor growth data were evaluated for statistical significance using Student's t test; reported P values are two-sided. Results: MAb C225 and oligonucleotide HYB 190 inhibited colony formation in soft agar in a dose-dependent manner for all renal cancer cell lines tested, We observed a potentiation of growth inhibition and induction of apoptosis when 769-P cells and ACHN cells were treated with both agents. Combination treatment with MAb C225 and oligonucleotide HYB 190 caused regression of ACHN tumor xenografts, whereas single-agent treatment only delayed tumor growth. Conclusion: The combination of anti-EGFR MAb C225 and HYB 190 antisense PKAI oligonucleotides HYB 190 exhibited cooperative antiproliferative effects and cooperative antitumor effects on EGFR and PKAI-expressing human renal cancer cell Lines.
引用
收藏
页码:1087 / 1094
页数:8
相关论文
共 50 条
  • [31] Abnormal hair growth in a patient with head and neck cancer treated with the anti-epidermal growth factor receptor monoclonal antibody cetuximab
    Montagut, C
    Grau, JJ
    Grimalt, R
    Codony, J
    Ferrando, J
    Albanell, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) : 5273 - 5275
  • [32] Challenges in the development of anti-epidermal growth factor receptor therapies in breast cancer
    Arteaga, CL
    Truica, CI
    SEMINARS IN ONCOLOGY, 2004, 31 (01) : 3 - 8
  • [33] Determinants of RASistance to anti-epidermal growth factor receptor agents
    Baselga, Jose
    Rosen, Neal
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) : 1582 - 1584
  • [34] Anti-epidermal growth factor receptor therapy for glioblastoma in adults
    Lee, Adrian
    Arasaratnam, Malmaruha
    Chan, David Lok Hang
    Khasraw, Mustafa
    Howell, Viive M.
    Wheeler, Helen
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (05):
  • [35] Anti-Epidermal Growth Factor Receptor Gene Therapy for Glioblastoma
    Hicks, Martin J.
    Chiuchiolo, Maria J.
    Ballon, Douglas
    Dyke, Jonathan P.
    Aronowitz, Eric
    Funato, Kosuke
    Tabar, Viviane
    Havlicek, David
    Fan, Fan
    Sondhi, Dolan
    Kaminsky, Stephen M.
    Crystal, Ronald G.
    PLOS ONE, 2016, 11 (10):
  • [36] Versatile Method for the Site-Specific Modification of DNA with Boron Clusters: Anti-Epidermal Growth Factor Receptor (EGFR) Antisense Oligonucleotide Case
    Ebenryter-Olbinska, Katarzyna
    Kaniowski, Damian
    Sobczak, Milena
    Wojtczak, Blazej A.
    Janczak, Slawomir
    Wielgus, Ewelina
    Nawrot, Barbara
    Lesnikowski, Zbigniew J.
    CHEMISTRY-A EUROPEAN JOURNAL, 2017, 23 (65) : 16535 - 16546
  • [37] Leukocytoclastic vasculitis with purpura and renal failure induced by the anti-epidermal growth factor receptor antibody panitumumab: a case report
    Hitomi Kamo
    Eiji Shinozaki
    Takanobu Sugase
    Nobuyuki Mizunuma
    Shoji Taniguchi
    Takashi Gotoh
    Keisyo Chin
    Tomoaki Tanaka
    Kazumi Koga
    Kensei Yamaguchi
    Journal of Medical Case Reports, 13
  • [38] Genetic factors influencing anti-epidermal growth factor receptor (EGFR) antibody toxicity to the skin
    Jaka, A.
    Ormaechea, N.
    Gutierrez-Rivera, A.
    Vildosola, S.
    Lopez-Pestana, A.
    Sarasqueta, C.
    La Casta, A.
    Izeta, A.
    Tuneu, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S182 - S182
  • [39] Hepatocellular carcinoma treated with anti-epidermal growth factor receptor antibody nimotuzumab A case report
    Song, Peng
    Yang, Jing
    Li, Xiaomei
    Huang, Haili
    Guo, Xueguang
    Zhou, Gang
    Xu, Xian
    Cai, Yi
    Zhu, Min
    Wang, Peng
    Zhao, Shu
    Zhang, Dong
    MEDICINE, 2017, 96 (39)
  • [40] MONOCLONAL ANTI-EPIDERMAL GROWTH-FACTOR RECEPTOR ANTIBODIES WHICH ARE INHIBITORS OF EPIDERMAL GROWTH-FACTOR BINDING AND ANTAGONISTS OF EPIDERMAL GROWTH FACTOR-STIMULATED TYROSINE PROTEIN-KINASE ACTIVITY
    GILL, GN
    KAWAMOTO, T
    COCHET, C
    LE, A
    SATO, JD
    MASUI, H
    MCLEOD, C
    MENDELSOHN, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1984, 259 (12) : 7755 - 7760